Moderna’s customers are lining up to order its coronavirus vaccine even though it's still in the experimental state.“We have received approximately $400 million of customer deposits for potential supply.
As we pivot to a commercial-stage company, we recognize the need for responsible pricing in the face of the pandemic,” CEP Stéphane Bancel said in the company's earnings release.Pricing for smaller volumes will likely range between $32 and $37 per dose, Bancel added on the company’s conference call, while larger volumes could be lower.RELATED: CoronavirusNOW.com, FOX launches national hub for COVID-19 news and updatesThe stock, which has gained over 284 percent this year on hopes of a vaccine, fell on Wednesday.Phase 2 U.S.